CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts ; volume:12 ; number:1 ; day:29 ; month:7 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (29.7.2022), 1-10, 12.2022
- Urheber
-
Huang, Licai
Wang, Jing
Fang, Bingliang
Meric-Bernstam, Funda
Roth, Jack A.
Ha, Min Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-16933-6
- URN
-
urn:nbn:de:101:1-2022101510281557701802
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Licai
- Wang, Jing
- Fang, Bingliang
- Meric-Bernstam, Funda
- Roth, Jack A.
- Ha, Min Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Patient-derived xenografts: a relevant preclinical model for drug development
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Factors associated with engraftment success of patient-derived xenografts of breast cancer
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Patient-derived xenografts: a relevant preclinical model for drug development
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Factors associated with engraftment success of patient-derived xenografts of breast cancer
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Patient-derived xenografts as preclinical neuroblastoma models
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Molecular profiling of patient-derived breast cancer xenografts
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Patient-derived xenografts as compatible models for precision oncology
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
Patient-derived xenografts: a relevant preclinical model for drug development
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts
Factors associated with engraftment success of patient-derived xenografts of breast cancer